MRM News

MRM Health obtém aprovação da FDA para iniciar seu ensaio clínico de fase 2b do MH002 em colite ulcerativa leve a moderada

MRM Health獲美國FDA新藥臨床試驗申請(IND)核准，啟動MH002治療輕中度潰瘍性結腸炎的第2b期臨床試驗

MRM Health获美国FDA新药临床试验申请(IND)批准，启动MH002治疗轻中度溃疡性结肠炎的2b期临床试验

MRM Health obtient l'autorisation IND de la FDA pour lancer son essai de phase 2b sur le MH002 dans le traitement de la rectocolite hémorragique légère à modérée

MRM Health erhält FDA-Zulassung für Start der Phase-2b-Studie mit MH002 bei leichter bis mittelschwerer Colitis ulcerosa

MRM Health krijgt IND-goedkeuring van FDA voor Fase 2b-onderzoek van MH002 bij milde tot matige colitis ulcerosa

World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku’s “Orb” Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately Two Months

MEDIROM Partners with World on Technology Envisioned by Sam Altman and Alex Blania: Deploying “Proof of Human” Infrastructure throughout Japan

MEDIROM Partners with World

MEDIROM Mother Labs Partners with TD SYNNEX to Accelerate National Adoption of "MOTHER Bracelet" and "REMONY"